Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer

The efficacy and safety of a combination of docetaxel (Taxotere; Rhône-Poulenc Rorer, Antony, France) and vinorelbine were evaluated in two phase II studies including 46 and 39 chemotherapy-naive patients with non-small cell lung cancer, respectively. In the first study, vinorelbine 25 mg/m2 was giv...

Full description

Saved in:

Bibliographic Details
Published in:	Seminars in oncology Vol. 24; no. 4 Suppl 14; p. S14
Main Authors:	Georgoulias, V, Kourousis, C, Androulakis, N, Kakolyris, S, Papadakis, E, Bouros, D, Apostolopoulou, F, Georgopoulou, T, Agelidou, M, Souglakos, J, Halkiadakis, G, Hatzidaki, D
Format:	Journal Article
Language:	English
Published:	United States 01-08-1997
Subjects:	Adult Aged Antineoplastic Agents, Phytogenic - therapeutic use Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Cisplatin - administration & dosage Clinical Trials as Topic Female Humans Lung Neoplasms - drug therapy Male Middle Aged Paclitaxel - analogs & derivatives Paclitaxel - therapeutic use Taxoids Vinblastine - administration & dosage Vinblastine - analogs & derivatives
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!